AI-generated summary
The authors report a randomized, placebo-controlled trial of 1072 nm infrared light therapy for recurrent herpes simplex labialis in 87 patients, comparing it with sham light. The active group had a median healing time of 129 hours versus 177 hours for controls, a difference the authors describe as significant, while time to crusting did not differ.
- Participants
- 87
- Who or what was studied
- Patients with recurrent herpes simplex labialis
- Wavelengths
- 1072 nm
- Limits stated in the abstract
- The abstract does not describe limitations of the trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on academic.oup.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1072 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Light-emitting diode, Placebo-controlled, Control group, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.